OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?
Elena Ortiz‐Zapater, Jaime Signes‐Costa, Paula Montero, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1423-1423
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease
Maria‐Elpida Christopoulou, Eleni Papakonstantinou, Daiana Stolz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3786-3786
Open Access | Times Cited: 39

Epithelial–Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?
Angélique Mottais, Luca Riberi, Andrea Falco, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12412-12412
Open Access | Times Cited: 31

The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression
Yosuke Kanno
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1796-1796
Open Access | Times Cited: 29

Emerging delivery approaches for targeted pulmonary fibrosis treatment
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 27

Recent Developments in the Role of Histone Acetylation in Asthma
Daniel P. Potaczek, Stanisława Bazan‐Socha, Ewa Wypasek, et al.
International Archives of Allergy and Immunology (2024) Vol. 185, Iss. 7, pp. 641-651
Closed Access | Times Cited: 10

Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1

Pre‐clinical evidence of a dual NADPH oxidase 1/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis
Victor J. Thannickal, Karin Jandeleit‐Dahm, Cédric Szyndralewiez, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 4, pp. 471-481
Open Access | Times Cited: 21

Single-Cell RNA Sequencing Provides New Insights into Therapeutic Roles of Thyroid Hormone in Idiopathic Pulmonary Fibrosis
Lan Wang, Zhongzheng Li, Ruyan Wan, et al.
American Journal of Respiratory Cell and Molecular Biology (2023) Vol. 69, Iss. 4, pp. 456-469
Open Access | Times Cited: 19

Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis
Ahmed Raslan, Tho X. Pham, Jisu Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

Therapeutic targeting of TGF‐β in lung cancer
Sajjad Aftabi, Amir Barzegar Behrooz, Marco Cordani, et al.
FEBS Journal (2024)
Open Access | Times Cited: 7

Multi-Step Extracellular Matrix Remodelling and Stiffening in the Development of Idiopathic Pulmonary Fibrosis
Constança Júnior, Anna Ulldemolins, Maria Narciso, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1708-1708
Open Access | Times Cited: 14

Molecular changes underlying pulmonary emphysema and chronic bronchitis in Chronic Obstructive Pulmonary Disease: An updated review.
Elia Ana Baltazar-García, Belinda Vargas‐Guerrero, Luz Elena Gasca-Lozano, et al.
PubMed (2024) Vol. 39, Iss. 7, pp. 805-816
Closed Access | Times Cited: 5

Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
Vaishali Singh, Ilya V. Ulasov, Sachin Gupta, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 22-22
Open Access | Times Cited: 5

Harnessing self-assembled nanoplatform of Dexamethasone and α-linolenic acid for high-efficiency inhibition of pulmonary cytokine storm and fibrosis in mice
Hongbing Liu, Muse Ji, Yi Qin, et al.
Nano Today (2024) Vol. 55, pp. 102201-102201
Closed Access | Times Cited: 4

The epithelium takes the stage in asthma and inflammatory bowel diseases
Rocío López-Posadas, Dustin Bagley, Carlos Pardo-Pastor, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4

What Every Clinician Should Know About Inflammation in COPD
Michael E. Wechsler, J. Michael Wells
ERJ Open Research (2024) Vol. 10, Iss. 5, pp. 00177-2024
Open Access | Times Cited: 4

Ameliorative effects of avocado oil on bleomycin‐induced lung fibrosis and oxidative stress in rats
Naoures Ochi, Anouar Abidi, Wael Taamalli, et al.
Physiological Reports (2025) Vol. 13, Iss. 3
Open Access

Role of macrophages in peritoneal dialysis-associated peritoneal fibrosis
Chenling Chu, Ying Huang, Luxi Cao, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access

Nutrition, Lifestyle, and Environmental Factors in Lung Homeostasis and Respiratory Health
Athanasios Pouptsis, Rosa Zaragozá, Elena R. García‐Trevijano, et al.
Nutrients (2025) Vol. 17, Iss. 6, pp. 954-954
Open Access

Proinflammatory Cytokines in Chronic Respiratory Diseases and Their Management
Vivek P. Chavda, Rajashri Bezbaruah, Nasima Ahmed, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 400-400
Open Access

Metabolomic Biomarkers of Pulmonary Fibrosis in COVID‐19 Patients One Year After Hospital Discharge
Marina Botello‐Marabotto, Julia Tarrasó, Alba Mulet, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 3
Closed Access

Page 1 - Next Page

Scroll to top